Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates
- PMID: 28004188
- DOI: 10.1007/s00431-016-2830-7
Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates
Abstract
In this prospective study, we compared the efficacy and side effects of indomethacin, ibuprofen, and paracetamol in patent ductus arteriosus (PDA) closure in preterm neonates. Three hundred preterm neonates with hemodynamically significant PDA (hs-PDA) admitted at our neonatal intensive care unit were enrolled in the study. They were randomized into three groups. Group I (paracetamol group) received 15 mg/kg/6 h IV paracetamol infusion for 3 days. Group II (ibuprofen group) received 10 mg/kg IV ibuprofen infusion followed by 5 mg/kg/day for 2 days. Group III (indomethacin group) received 0.2 mg/kg/12 h indomethacin IV infusion for three doses. Laboratory investigations such as renal function test, liver function test, complete blood count, and blood gases were conducted in addition to echocardiographic examinations. All investigations were done before and 3 days after treatment. There was no significant difference between all groups regarding efficacy of PDA closure (P = 0.868). There was a significant increase in serum creatinine levels and serum blood urea nitrogen (BUN) in the ibuprofen and indomethacin groups (P < 0.001). There was a significant reduction in platelet count and urine output (UOP) in both ibuprofen and indomethacin groups (P < 0.001). There was a significant increase in bilirubin levels in only the ibuprofen group (P = 0.003). No significant difference of hemoglobin (HB) level or liver enzymes in all groups (P > 0.05). Ventilatory settings improved significantly in patients with successful closure of PDA than those with failed PDA closure (P < 0.001).
Conclusion: Paracetamol is as effective as indomethacin and ibuprofen in closure of PDA in preterm neonates and has less side effects mainly on renal function, platelet count, and GIT bleeding. What is Known: • Hemodynamically significant patent ductus arteriosus has many complications for preterm and low birth weight neonates and better to be closed. Many drugs were used for medical closure of PDA e.g. indomethacin, ibuprofen and recently paracetamol. Many studies compare safety and efficacy of paracetamol with either indomethacin or ibuprofen. What is New: • It is the first large study that compares the efficacy and side effects of the three drugs in one study.
Keywords: Ibuprofen; Indomethacin; PDA closure; Paracetamol; Preterm neonate.
Comment in
-
Is paracetamol as effective as indomethacin or ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants?Acta Paediatr. 2018 Oct;107(10):1836. doi: 10.1111/apa.14438. Epub 2018 Jun 28. Acta Paediatr. 2018. PMID: 29873417 No abstract available.
Similar articles
-
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.Cochrane Database Syst Rev. 2020 Jan 27;1(1):CD010061. doi: 10.1002/14651858.CD010061.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Dec 15;12:CD010061. doi: 10.1002/14651858.CD010061.pub5. PMID: 31985831 Free PMC article. Updated.
-
Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial.J Matern Fetal Neonatal Med. 2020 May;33(9):1587-1592. doi: 10.1080/14767058.2018.1525354. Epub 2018 Oct 29. J Matern Fetal Neonatal Med. 2020. PMID: 30227731 Clinical Trial.
-
Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.Trials. 2016 Apr 2;17:182. doi: 10.1186/s13063-016-1294-4. Trials. 2016. PMID: 27038924 Free PMC article. Clinical Trial.
-
Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.Pediatr Cardiol. 2014 Jun;35(5):824-30. doi: 10.1007/s00246-014-0861-2. Epub 2014 Jan 17. Pediatr Cardiol. 2014. PMID: 24435507 Clinical Trial.
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
Cited by
-
Efficacy and Costs of Three Pharmacotherapies for Patent Ductus Arteriosus Closure in Premature Infants.Paediatr Drugs. 2022 Mar;24(2):93-102. doi: 10.1007/s40272-022-00495-1. Epub 2022 Mar 1. Paediatr Drugs. 2022. PMID: 35229248
-
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults.Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD011725. doi: 10.1002/14651858.CD011725.pub2. Cochrane Database Syst Rev. 2019. PMID: 31752052 Free PMC article.
-
iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants.BMJ Open. 2023 Mar 23;13(3):e069314. doi: 10.1136/bmjopen-2022-069314. BMJ Open. 2023. PMID: 36958775 Free PMC article.
-
Dual medication therapy (acetaminophen and ibuprofen) for the management of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.J Perinatol. 2022 Dec;42(12):1654-1661. doi: 10.1038/s41372-022-01500-8. Epub 2022 Aug 25. J Perinatol. 2022. PMID: 36008521
-
Brain oxidative stress mediates anxiety-like behavior induced by indomethacin in zebrafish: protective effect of alpha-tocopherol.Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1715-1725. doi: 10.1007/s00210-023-02661-9. Epub 2023 Sep 18. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37721555 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical